Korea United Pharm Inc
KRX:033270

Watchlist Manager
Korea United Pharm Inc Logo
Korea United Pharm Inc
KRX:033270
Watchlist
Price: 20 750 KRW -0.48%
Market Cap: 305.3B KRW
Have any thoughts about
Korea United Pharm Inc?
Write Note

Korea United Pharm Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Korea United Pharm Inc
Revenue Peer Comparison

Comparables:
000100
326030
008930
128940
S
000250

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Korea United Pharm Inc
KRX:033270
Revenue
â‚©285.8B
CAGR 3-Years
9%
CAGR 5-Years
5%
CAGR 10-Years
7%
Yuhan Corp
KRX:000100
Revenue
â‚©1.9T
CAGR 3-Years
-3%
CAGR 5-Years
5%
CAGR 10-Years
7%
SK Biopharmaceuticals Co Ltd
KRX:326030
Revenue
â‚©354.9B
CAGR 3-Years
139%
CAGR 5-Years
218%
CAGR 10-Years
N/A
Hanmi Science Co Ltd
KRX:008930
Revenue
â‚©1.3T
CAGR 3-Years
13%
CAGR 5-Years
11%
CAGR 10-Years
13%
Hanmi Pharm Co Ltd
KRX:128940
Revenue
â‚©1.6T
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
8%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Revenue
â‚©204.3B
CAGR 3-Years
8%
CAGR 5-Years
4%
CAGR 10-Years
6%

See Also

What is Korea United Pharm Inc's Revenue?
Revenue
285.8B KRW

Based on the financial report for Jun 30, 2024, Korea United Pharm Inc's Revenue amounts to 285.8B KRW.

What is Korea United Pharm Inc's Revenue growth rate?
Revenue CAGR 10Y
7%

Over the last year, the Revenue growth was 5%. The average annual Revenue growth rates for Korea United Pharm Inc have been 9% over the past three years , 5% over the past five years , and 7% over the past ten years .

Back to Top